Remdesivir Has No Certificate of Product Registration — FDA

Remdesivir

Remdesivir has no Certificate of Product Registration, according to FDA. The Food and Drug Administration (FDA) said that Remdesivir has no Certificate of Product Registration (CPR) in the Philippines. Remdesivir was an investigational drug that was currently being used on patients with coronavirus disease (COVID-19) in the Philippines. On Monday, the Food and Drug Administration … Read more

DOH Warns Public vs Overpricing Remdesivir

Remdesivir

The DOH warned the public against overpricing of Remdesivir The Department of Health (DOH) on Friday released a statement as the agency warned the public against overpricing of Remdesivir. In a statement, the Department of Health said that a 100-milligram vial of Remdesivir must only cost PHP 1,500 to PHP 8,200 and the use of … Read more

Remdesivir Still Part Of Ongoing Clinical Trial In PH, Says DOH

Remdesivir

Remdesivir was still part of the ongoing clinical trial in the Philippines, according to the Department of Health. The Department of Health on Thursday evening said that the antiviral drug Remdesivir was still part of the ongoing clinical trial in the Philippines. This, as Undersecretary Maria Rosario Vergeire said in a statement that the antiviral … Read more

Japan Set To Authorize Remdesivir For COVID-19 Treatment

Remdesivir

Japan planned to approve Remdesivir in treating patients with COVID-19, according to the Japanese government. Japan on Thursday planned to approve the antiviral drug Remdesivir in treating patients with coronavirus disease 2019 or COVID-19, according to the Japanese government. Aside from this, Japan was also targeting to approve the anti-flu drug Avigan this month. Japan … Read more

US FDA Approves Remdesivir, Issues Emergency-use Authorization

US FDA

The US FDA approved the emergency use of Remdesivir in treating patients with severe COVID-19. US FDA — The Food and Drug Administration in the United States approved the emergency use of Remdesivir in treating patients with severe COVID-19. This, as US Food and Drug Administration Commissioner Stephen Hahn said that the experimental drug, Remdesivir, … Read more